Trial of Dasatinib in Patients With Advanced Cancers Harboring DDR2 Mutation or Inactivating B-RAF Mutation
Clinical trial NCT01514864 · TERMINATED
Trial details
- NCT number
- NCT01514864
- Sponsor
- Bristol-Myers Squibb
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-05-31
- Primary completion
- 2014-07-23
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.